Loading…
ANG Lifesciences India (BSE 540694)₹36.93−2.97%Pharmaceuticals
At the end of the Mar 2026 quarter, ANG Lifesciences India's shareholders were: promoters 70.61%, public 29.39%. Promoter holding is unchanged on the quarter. It had 5,953 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.61% | 70.61% | 70.61% | 70.61% | 70.61% | 70.61% | 70.61% | 70.61% | 70.61% | 70.61% | 70.61% | 70.61% |
| Public | 29.39% | 29.39% | 29.39% | 29.39% | 29.39% | 29.39% | 29.39% | 29.39% | 29.39% | 29.39% | 29.39% | 29.39% |
| Number of shareholders | 7,306 | 7,056 | 6,919 | 6,869 | 6,632 | 6,469 | 6,518 | 6,509 | 6,401 | 6,274 | 6,085 | 5,953 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Rajesh Gupta | Promoter | 70.42% | 0.00 |
| Saruchi Gupta | Promoter | 0.19% | 0.00 |
Promoters held 70.61% of ANG Lifesciences India at the end of the Mar 2026 quarter, the same as a year earlier.
ANG Lifesciences India had 5,953 shareholders at the end of the Mar 2026 quarter, against 6,509 a year earlier.